508 - Cabotegravir Long-Acting for Pre-Exposure Prophylaxis (PrEP): Real World Data on On-Time Dosing, HIV Testing and HIV Acquisition from the OPERA Cohort

Saturday, October 19, 2024

11:30 AM – 11:45 AM US PT

Location: 411

Co-Author(s)

AM

Anthony M. Mills, MD

Founder and CEO
Men's Health Foundation
Los Angeles, CA, United States(LAX-Los Angeles International Airport), California, United States

Co-Author(s)

LB

Laurence Brunet, PhD

Director of Epidemiology
Epividian, Inc.
Durham, North Carolina, United States
KF

Kevin R. Frost, BM

Chief Executive Officer
amfAR, The Foundation for AIDS Research
New York, New York, United States

Presenting Author(s)

Ricky Hsu, MD (he/him/his)

National Medical Director at the AIDS Healthcare Foundation and also an Associate Clinical Professor at Department of HIV and Internal Medicine,
AHF/ NYU Langone Medical Center
New York, NY, United States

Slides

Co-Author(s)

Gerald Pierone, Jr., MD (he/him/his)

Research Officer
Whole Family Health Center
Vero Beach, FL, United States
Michael G. Sension, MD

Medical Director
can community health
Miami Beach, FL, United States
PL

Philip C. Lackey, MD

Assistant Professor
Wake Forest University School of Medicine
Winston Salem, North Carolina, United States
KM

Karam Mounzer, MD (he/him/his)

Clinical Professor of Medicine The Perelman School of Medicine at the University of Pennsylvania
Philadelphia Fight Community Health Centers
Philadelphia, Pennsylvania, United States
MW

Michael B. Wohlfeiler, JD, MD, AAHIVS

Chief Medical Officer
AIDS Healthcare Foundation
Miami Beach, Florida, United States
Jennifer S. Fusco, BS

Chief Science Officer
Epividian, Inc.
Durham, North Carolina, United States
CB

Carolyn A. Brown, MSPH, PhD

ViiV Healthcare
Atlanta, Georgia, United States
Vani Vannappagari, MBBS, MPH, PhD

Global Head, Epidemiology & Real World Evidence
ViiV Healthcare
Research Triangle Park, North Carolina, United States
MA

Michael Aboud, MBChB, MRCP

Vice President & Head, International Medical Affairs
ViiV Healthcare
Brentford , Middlesex, England, United Kingdom
PB

Piotr Budnik, MBBCh FCP(SA)

Senior Medical Affairs Director
ViiV Healthcare
London, England, United Kingdom
GF

Gregory P. Fusco, MD, MPH

Chief Executive Officer & Chief Medical Officer
Epividian, Inc.
Durham, North Carolina, United States

Disclosure(s):

Anthony M. Mills, MD: Abbott: Grant/Research Support; Emit Bio: Grant/Research Support; Gilead: Advisor/Consultant, Grant/Research Support; Merck: Advisor/Consultant, Grant/Research Support; ViiV Healthcare: Advisor/Consultant, Grant/Research Support

Laurence Brunet, PhD: EMD Serono: Research support to my employer; Gilead Sciences: Research support to my employer; Merck & Co.: Research support to my employer; TheraTechnologies: Research support to my employer; ViiV Healthcare: Research support to my employer

Kevin R. Frost, BM: No financial relationships to disclose

Gerald Pierone, MD, Jr.: GSK: Grant/Research Support; VIIV: Grant/Research Support

Michael G. Sension, MD: Gilead: Grant/Research Support, Honoraria; Viiv: Honoraria

Philip C. Lackey, MD: No financial relationships to disclose

Karam Mounzer, MD: Epividian: Board Member, Honoraria; GS: Advisor/Consultant, Grant/Research Support, Honoraria; Merck: Advisor/Consultant; THERA Technologies: Grant/Research Support; ViiV healthcare: Advisor/Consultant, Grant/Research Support, Honoraria

Michael B. Wohlfeiler, JD, MD, AAHIVS: No financial relationships to disclose

Jennifer S. Fusco, BS: EMD Serono: Research support to my employer; Gilead Sciences: Research support to my employer; Merck & Co.: Research support to my employer; TheraTechnologies: Research support to my employer; ViiV Healthcare: Research support to my employer

Carolyn A. Brown, MSPH, PhD: ViiV Healthcare/GSK: Stocks/Bonds (Public Company)

Vani Vannappagari, MBBS, MPH, PhD: GSK: Stocks/Bonds (Public Company); ViiV Healthcare: Full time Employee, Stocks/Bonds (Public Company)

Michael Aboud, MBChB, MRCP: No financial relationships to disclose

Piotr Budnik, MBBCh FCP(SA): GSK: Stocks/Bonds (Public Company); ViiV Healthcare: Employee

Gregory P. Fusco, MD, MPH: EMD Serono: Research support to my employer; Gilead Sciences: Research support to my employer; Merck & Co.: Research support to my employer; TheraTechnologies: Research support to my employer; ViiV Healthcare: Research support to my employer